.jpeg)
Tivozanib price
Tivozanib is an oral, once-daily, new-generation vascular endothelial growth factor receptor (VEGFR) tyrosine kinase inhibitor (TKI). It is a potent and selective inhibitor of VEGFRs 1, 2, and 3 with a long half-life, designed to improve efficacy and tolerability. Tivozanib capsule was approved by the U.S. Food and Drug Administration in March 2021 for the treatment of adult patients with relapsed or refractory advanced renal cell carcinoma (RCC) after two or more systemic therapies. It is sold under the trade name FOTIVDA. The price of the European version of tivozanib Original drug, specifications 1340mcg*21 pills per box may be around 30,000 yuan (the price may fluctuate due to the exchange rate), which is relatively expensive.
[ 免责声明 ] 本页面内容来自公开渠道（如FDA官网、Drugs官网、原研药厂官网等），仅供持有医疗专业资质的人员用于医学药学研究参考，不构成任何治疗建议或药品推荐。所涉药品可能未在中国大陆获批上市，不适用于中国境内销售和使用。如需治疗，请咨询正规医疗机构。本站不提供药品销售或代购服务。
